Herbal Dispatch Reports First Quarter 2026 Results and Provides Business Update

Executive Summary

• Herbal Dispatch reported Q1 2026 financial results while detailing a strategic pivot toward higher-margin, recurring revenue channels including veteran/insured-patient medical cannabis, proprietary house brands, and international exports.
• Direct-to-consumer medical revenue nearly doubled year-over-year to $761,375, driven by aggressive expansion of the insurance-focused service model and concierge patient onboarding.
• The company highlighted substantial post-quarter momentum in exports, completing over 1,321kg in medical cannabis shipments globally and securing $200,000 in Export Development Canada-backed financing to accelerate international growth.

Key Details

• Q1 2026 Revenue Growth: Direct-to-consumer medical revenue increased approximately 98% year-over-year, rising from $383,912 in Q1 2025 to $761,375 in Q1 2026.
• Patient Acquisition & Economics: Currently onboarding ~50 new insured patients per month; veteran patients generate ~$6,000 in annual insured medical cannabis spending per patient, creating a highly recurring revenue stream.
• Proprietary Brand Expansion: Company now operates five proprietary cannabis brands encompassing more than 40 SKUs across flower, pre-rolls, edibles, vapes, and concentrates.
• International Export Milestones: Since January 2026, completed international shipments totaling ~1,321kg of medical cannabis, including a 298kg shipment to Germany, a 500kg export to Europe, a subsequent 262kg European export, and the inaugural export of medical cannabis gummies to Australia.
• Strategic Infrastructure Investments: Advancing development of a Medical Clinic to strengthen vertical integration, enhance patient journey capture, and improve insurance-supported medical cannabis services.
• Technology & AI Focus: Continuing capital allocation toward technology, automation, and artificial intelligence capabilities to improve operational efficiency, data-driven decision-making, and customer acquisition/retention.
• Financing & Capital Structure: Secured $200,000 in export financing backed by Export Development Canada programs to provide additional working capital for larger, more frequent international transactions.
• Financial Reports: Consolidated financial statements and MD&A for the three months ended March 31, 2026 are available on SEDAR+ and the company website.

Notable Quotes

• Philip Campbell, CEO: "The first quarter was fundamentally about repositioning the business for where we see the greatest long-term opportunities. We made a decision to allocate resources toward veterans, exports, house brands, and other recurring revenue channels that we believe can generate significantly greater shareholder value over time."
• Philip Campbell, CEO: "While transitions of this nature can temporarily impact financial performance, we are already beginning to see the benefits emerge. The momentum we have experienced since quarter-end-including export activity, veteran onboarding, new export relationships, expanding house brands, and enhanced financing capabilities-gives us confidence that these strategic decisions are bearing fruit."
• Philip Campbell, CEO: "Our objective is to build a stronger, more scalable company with better margins, broader brand offerings, and multiple long-term growth engines. We believe the work completed during the first quarter has laid important groundwork toward achieving that objective."